Tower Research Capital LLC (Trc) Bio Restorative Therapies, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Restorative Therapies, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,795 shares of BRTX stock, worth $7,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,795
Previous 2,661
80.2%
Holding current value
$7,480
Previous $3,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BRTX
# of Institutions
14Shares Held
249KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA52.3KShares$81,6450.0% of portfolio
-
Stone X Group Inc.50.1KShares$78,1560.01% of portfolio
-
Wealth Alliance Mellville, NY40KShares$62,4000.01% of portfolio
-
Ubs Group Ag27.8KShares$43,3880.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.5KShares$31,9360.0% of portfolio
About BioRestorative Therapies, Inc.
- Ticker BRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,650,030
- Market Cap $5.69M
- Description
- BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtx...